The present invention relates to a pharmaceutical composition against influenza virus.  The pharmaceutical composition comprises a therapeutically effective amount of the extract of Sanguisorba officinalis L., or active compounds obtained from the extract of S. officinalis and the corresponding hydrolyzed compound.

The present invention relates to a pharmaceutical composition against influenza virus.  The pharmaceutical composition comprises a therapeutically effective amount of the extract of Sanguisorba officinalis L., or active compounds obtained from the extract of S. officinalis and the corresponding hydrolyzed compound.
The present invention relates to a pharmaceutical composition against influenza virus.  The pharmaceutical composition comprises a therapeutically effective amount of the extract of Sanguisorba officinalis L., or active compounds obtained from the extract of S. officinalis and the corresponding hydrolyzed compound.

本發明提供全新選擇之藥物或健康食品，對於抗流感具有高效、毒性低、量產容易且成本低廉等優特點，適合國內生醫科技產業發展。